These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27264036)

  • 1. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry.
    Riva N; Ageno W; Schulman S; Beyer-Westendorf J; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Dentali F;
    Lancet Haematol; 2016 Jun; 3(6):e267-75. PubMed ID: 27264036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
    Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
    JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.
    Riva N; Ageno W; Poli D; Testa S; Rupoli S; Santoro R; Lerede T; Piana A; Carpenedo M; Nicolini A; Ferrini PM; Tosetto A; ;
    J Thromb Haemost; 2015 Jun; 13(6):1019-27. PubMed ID: 25845412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study.
    Søgaard KK; Adelborg K; Darvalics B; Horváth-Puhó E; Beyer-Westendorf J; Ageno W; Sørensen HT
    Lancet Haematol; 2018 Oct; 5(10):e441-e449. PubMed ID: 30201587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy.
    Condat B; Pessione F; Hillaire S; Denninger MH; Guillin MC; Poliquin M; Hadengue A; Erlinger S; Valla D
    Gastroenterology; 2001 Feb; 120(2):490-7. PubMed ID: 11159889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
    Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
    Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.
    Senzolo M; Riva N; Dentali F; Rodriguez-Castro K; Sartori MT; Bang SM; Martinelli I; Schulman S; Alatri A; Beyer-Westendorf J; Di Minno MND; Ageno W;
    Clin Transl Gastroenterol; 2018 Aug; 9(8):176. PubMed ID: 30108204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience.
    Rupoli S; Fiorentini A; Morsia E; Svegliati-Baroni G; Micucci G; Maroni L; Garvey KB; Fiorentini A; Riva A; Da Lio L; Benedetti A; Offidani M; Olivieri A; Giuseppe T
    Vasc Health Risk Manag; 2021; 17():619-629. PubMed ID: 34594107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry.
    Ageno W; Riva N; Schulman S; Bang SM; Sartori MT; Grandone E; Beyer-Westendorf J; Barillari G; Di Minno MN; Dentali F;
    Semin Thromb Hemost; 2014 Feb; 40(1):99-105. PubMed ID: 24381147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.
    Violi F; Corazza GR; Caldwell SH; Perticone F; Gatta A; Angelico M; Farcomeni A; Masotti M; Napoleone L; Vestri A; Raparelli V; Basili S;
    Intern Emerg Med; 2016 Dec; 11(8):1059-1066. PubMed ID: 27026379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
    De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
    Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors.
    Ollivier-Hourmand I; Lebedel L; Alabau BB; Goria O; Bureau C; Dumortier J; Heurgué A; Silvain C; De-Ledinghen V; Rautou PE; Payancé A; Ballester TG; Alvarado-Tapias E; Hernández-Gea V; Valla D; Zekrini K; Nga Nguyen TT; Dao T; Garcia Pagan JC; Morello R; Plessier A
    J Hepatol; 2024 Sep; 81(3):451-460. PubMed ID: 38679069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital.
    Jørgensen CT; Tavoly M; Førsund E; Pettersen HH; Tjønnfjord E; Ghanima W; Brækkan SK
    J Thromb Haemost; 2023 Oct; 21(10):2824-2832. PubMed ID: 37394122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis.
    Candeloro M; Valeriani E; Monreal M; Ageno W; Riva N; Schulman S; Bang SM; Mellado M; Díaz-Peromingo JA; Moisés J; Díaz-Brasero AM; Garcia-Pagan JC; Perez-Campuzano V; Senzolo M; De Gottardi A; Di Nisio M
    J Thromb Haemost; 2023 Jun; 21(6):1592-1600. PubMed ID: 36907381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, Management, and Implications of Visceral Thrombosis in Pancreatic Ductal Adenocarcinoma.
    Mier-Hicks A; Raj M; Do RK; Yu KH; Lowery MA; Varghese A; O'Reilly EM
    Clin Colorectal Cancer; 2018 Jun; 17(2):121-128. PubMed ID: 29477452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.
    Tufano A; Ageno W; Di Micco P; Niglio A; Rosa V; Ballaz A; Braester A; Rubio CM; Isern V; Imbalzano E; Monreal M;
    Thromb Res; 2018 Apr; 164():69-74. PubMed ID: 29499439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and recurrence in patients with splanchnic vein thromboses.
    Thatipelli MR; McBane RD; Hodge DO; Wysokinski WE
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):200-5. PubMed ID: 19782767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial management of noncirrhotic splanchnic vein thrombosis: when is anticoagulation enough?
    Ravichandran P; Croome KP; Kovacs MJ; Lazo-Langner A; Hernandez-Alejandro R
    Can J Gastroenterol Hepatol; 2014 Apr; 28(4):207-11. PubMed ID: 24729995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis.
    Baiges A; Procopet B; Silva-Junior G; Llop E; Tellez L; Darnell A; Garcia-Criado Á; Turon F; Nicoara-Farcau O; González-Alayón C; Larrue H; Magaz M; Olivas P; Perez-Campuzano V; Calleja JL; Albillos A; Reverter JC; Bureau C; Bosch J; Hernández-Gea V; Garcia-Pagán JC; ; ;
    J Hepatol; 2023 Jan; 78(1):114-122. PubMed ID: 36058365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.